Abstract:BACKGROUND/AIM:GlyH-101 and CaCCinh-A01 are effective blockers of cystic fibrosis transmembrane conductance regulator (CFTR) and Ca2+-activated chloride channels (CaCCs), respectively. Available evidence suggests that GlyH-101 and CaCCinh-A01 can suppress cell proliferation, block invasion and metastasis, and cause several cancer cell types to undergo apoptosis, demonstrating their anti-tumor properties. The aim of this study was to investigate the effect of GlyH-101 and CaCCinh-A01 on HT-29 cell activity and to suggest the possible molecular mechanisms by which inhibitors of CFTR and CaCCs inhibit HT-29 cell activity.MATERIALS AND METHODS:Human colon HT-29 cancer cells were treated with GlyH-101 or CaCCinh-A01 or GlyH-101 plus CaCCinh-A01 complex. Cell viability was determined by MTT assay, the apoptosis and cell cycle were determined by flow cytometry, and reactive oxygen species (ROS) leves were determined by 2',7'-Dichlorodihydrofluorescein diacetate staining. The expression of proteins related to apoptosis and cell cycle regulation was measured by western blotting.RESULTS:The proliferative ability of HT-29 cells was dose- and time-dependently reduced by GlyH-101 and CaCCinh-A01. Treatment with GlyH-101 and CaCCinh-A01 resulted in cell necrosis and apoptosis, up-regulated ROS levels, activated the mitochondrial apoptosis pathway, prompted arrest of the cell cycle in S phase, and increased the levels of proteins related to the cell cycle. Additionally, the combination of these two inhibitors had a stronger regulatory effect on HT-29 cell proliferation than either GlyH-101 or CaCCinh-A01 treated alone.CONCLUSION:GlyH-101 and CaCCinh-A01 inhibited cell proliferation through cell cycle arrest and mitochondrial-related pathways in vitro. The combination of these inhibitors could further enhance their anti-proliferative effects. Our findings propose new lead compounds with anti-colon cancer activity, and also provide new evidence for the effectiveness of chloride channels-targeted therapy in anticancer therapy.

Effect of a Fraction of the Chloroform Extract from Pholidota Yunnanesis Rolfe on the HepG2 Cells' Cell Cycle

Study the effect of Phenylacetate induced differentiation on colorectal cancer cell

Inhibitory Effect of Platycodin D on Human Colonic Cancer SW620 Cell Proliferation

The Anti-timour Effect of Ethanol Extract of Rhizoma Atractylodis on Lung Cancer A549 Cells

The anti-timour effect of ethanol extract of Rhizoma Atractylodis on SKOV-3 cells

Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.

Effect of lithium chloride on proliferation and cell cycle of human hepatoma cells

Effects of PolyphyllinⅡ in Growth Inhibition of Human Breast Cancer Cells

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

[Effects of Matrine on the Relative Molecules Expression of Proliferation and Apoptosis in K562 Cells].

A Resveratrol Analog, Phoyunbene B, Induces G2/M Cell Cycle Arrest and Apoptosis in HepG2 Liver Cancer Cells.

[Damage effect of Polygonum multiflorum fractions on human normal liver cells L02 and liver cancer cells HepG2]

Mechanism study of protobioside on tumor cell proliferation

Investigation Of The Anti-Cancer Effect Of Quercetin On Hepg2 Cells In Vivo

Inhibiting Effect of Phyllanthus Urinaria Alcohol Extract on Human Stomach Cancer Cell MKN28

GlyH-101 and CaCCinh-A01 Inhibited HT-29 Proliferation by Activating the Mitochondrial Apoptosis Pathway and Arresting the Cell Cycle.

Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells.

The mechanism of Grifola polysaccharide inhibiting hepatocellular carcinoma cells

Effect of Matrine on Inhibiting Proliferation and Inducing Apoptosis of Human Intestinum Crassum Carcinoma HT29 Cells

Effects of Tetrandrine on apoptosis and cell cycle of human choriocarcinoma BeWo cells

A novel pyrrolidine-2,5-dione derivative induced G2/M phase arrest and apoptosis of hepatocellular carcinoma HepG2 cells through inhibiting tubulin polymerization